C-Terminal Amidation of Chlorotoxin Does Not Affect Tumour Cell Proliferation and Has No Effect on Toxin Cytotoxicity

No abstract is available for this paper.

• Publication year

  2020

• Venue

  International Journal of Peptide Research and Therapeutics

• Publication date

  2020-09-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/S10989-020-10117-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chlorotoxin targets ERα/VASP signaling pathway to combat breast cancer

  2019cited by this paper
• Strategies for the Identification of Bioactive Neuropeptides in Vertebrates

  2019cited by this paper
• The Dual α-Amidation System in Scorpion Venom Glands

  2019cited by this paper
• Neuropilin-1 drives tumor-specific uptake of chlorotoxin

  2019cited by this paper
• A C-Terminal Fragment of Chlorotoxin Retains Bioactivity and Inhibits Cell Migration

  2019cited by this paper
• Venom as therapeutic weapon to combat dreadful diseases of 21st century: A systematic review on cancer, TB, and HIV/AIDS.

  2018cited by this paper
• Screening, large-scale production, and structure-based classification for cystine-dense peptides

  2018cited by this paper
• Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors

  2018cited by this paper
• Lysine to arginine mutagenesis of chlorotoxin enhances its cellular uptake

  2017cited by this paper
• Chlorotoxin: Structure, activity, and potential uses in cancer therapy

  2016cited by this paper
• Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential

  2016cited by this paper
• Snapshots of scorpion venomics

  2015cited by this paper
• Chlorotoxin: A Helpful Natural Scorpion Peptide to Diagnose Glioma and Fight Tumor Invasion

  2015cited by this paper
• Antimicrobial peptides from scorpion venoms

  2014cited by this paper
• Scorpion venom components as potential candidates for drug development

  2014cited by this paper
• Functional and structural study comparing the C-terminal amidated β-neurotoxin Ts1 with its isoform Ts1-G isolated from Tityus serrulatus venom.

  2014cited by this paper
• The role of disulfide bonds in structure and activity of chlorotoxin.

  2014cited by this paper
• Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells.

  2012cited by this paper
• Solution structure of native and recombinant expressed toxin CssII from the venom of the scorpion Centruroides suffusus suffusus, and their effects on Nav1.5 sodium channels.

  2012cited by this paper
• Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma

  2011cited by this paper
• Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.

  2011cited by this paper
• Addition of positive charges at the C-terminal peptide region of CssII, a mammalian scorpion peptide toxin, improves its affinity for sodium channels Nav1.6.

  2011cited by this paper
• Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.

  2010cited by this paper
• Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3.

  2010cited by this paper
• Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.

  2010cited by this paper
• Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects

  2009cited by this paper
• Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.

  2008cited by this paper
• Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.

  2006cited by this paper
• Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution.

  2005cited by this paper
• Expression of the standard scorpion alpha-toxin AaH II and AaH II mutants leading to the identification of some key bioactive elements.

  2005cited by this paper
• Imaging glioma extent with 131I-TM-601.

  2005cited by this paper
• Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice

  2004cited by this paper
• Molecular cloning and functional expression of the alpha-scorpion toxin BotIII: pivotal role of the C-terminal region for its interaction with voltage-dependent sodium channels.

  2004cited by this paper
• Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2*

  2003cited by this paper
• Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin

  2002cited by this paper
• Modulation of Glioma Cell Migration and Invasion Using Cl− and K+ Ion Channel Blockers

  1999cited by this paper
• Use of chlorotoxin for targeting of primary brain tumors.

  1998cited by this paper
• Consequence of the removal of evolutionary conserved disulfide bridges on the structure and function of charybdotoxin and evidence that particular cysteine spacings govern specific disulfide bond formation.

  1998cited by this paper
• NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels.

  1995cited by this paper
• Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion.

  1993cited by this paper
• Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus.

  1991cited by this paper

• Arthropod venom peptides: Pioneering nanotechnology in cancer treatment and drug delivery

  2025cites this paper
• “Advances in the Use of Chitosan and Chlorotoxin- Functionalized Chitosan Polymers in Drug Delivery and Detection of Glioma - A Review"

  2024cites this paper
• Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles

  2023cites this paper
• Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery

  2022cites this paper